Rave over: FDA shuts down MDMA therapy

The podcast discusses the FDA's decision against MDMA therapy, impacting psychedelic medicine stocks. It also covers economic updates on US private sector employment and ISM Services PMI. Additionally, it talks about the scrutiny faced by GameStop investor Keith Gill from the Massachusetts Securities Regulator, along with financial news updates on stock manipulation, spikes in stock prices, earnings reports, and investment recommendations.